- Home
- OFG vs ZLAB Comparison
OFG vs ZLAB Comparison
Compare OFG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- ZLAB
- Stock Information
- Founded
- OFG 1964
- ZLAB 2013
- Country
- OFG United States
- ZLAB China
- Employees
- OFG N/A
- ZLAB N/A
- Industry
- OFG Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- OFG Finance
- ZLAB Health Care
- Exchange
- OFG Nasdaq
- ZLAB Nasdaq
- Market Cap
- OFG 2.0B
- ZLAB 2.2B
- IPO Year
- OFG N/A
- ZLAB 2017
- Fundamental
- Price
- OFG $40.45
- ZLAB $19.88
- Analyst Decision
- OFG Buy
- ZLAB Buy
- Analyst Count
- OFG 4
- ZLAB 6
- Target Price
- OFG $45.75
- ZLAB $57.22
- AVG Volume (30 Days)
- OFG 307.4K
- ZLAB 931.8K
- Earning Date
- OFG 10-22-2025
- ZLAB 11-06-2025
- Dividend Yield
- OFG 3.05%
- ZLAB N/A
- EPS Growth
- OFG 6.55
- ZLAB N/A
- EPS
- OFG 4.40
- ZLAB N/A
- Revenue
- OFG $624,004,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- OFG N/A
- ZLAB $40.71
- Revenue Next Year
- OFG $1.09
- ZLAB $50.42
- P/E Ratio
- OFG $8.93
- ZLAB N/A
- Revenue Growth
- OFG N/A
- ZLAB 24.14
- 52 Week Low
- OFG $33.15
- ZLAB $19.51
- 52 Week High
- OFG $47.66
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- OFG 51.09
- ZLAB 18.64
- Support Level
- OFG $39.19
- ZLAB $19.51
- Resistance Level
- OFG $40.38
- ZLAB $20.29
- Average True Range (ATR)
- OFG 0.81
- ZLAB 0.76
- MACD
- OFG 0.11
- ZLAB 0.02
- Stochastic Oscillator
- OFG 64.19
- ZLAB 7.44
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.